Protective role of Th17 cells in pulmonary infection

Vaccine

Volumn 34, Issue 13, 2016, Pages 1504-1514

  Rathore, Jitendra Singh ^a,b   Wang, Yan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GAUTAM BUDDHA UNIVERSITY   (India)

Author keywords

IL 17; Lung; Pulmonary infection; Th17 cells

Indexed keywords

ALPHA INTERFERON; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; IL17A PROTEIN, HUMAN; IL17F PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-22;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PLASTICITY; HOST RESISTANCE; HUMAN; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; VIRUS INFECTION; ANIMAL; IMMUNOLOGY; LUNG DISEASE; MUCOSAL IMMUNITY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-17; INTERLEUKINS; LUNG DISEASES; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84960467221     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.02.021     Document Type: Review

References (186)

1. McGeachy M.J., Cua D.J. Th17 cell differentiation: the long and winding road. Immunity 2008, 28:445-453.
2. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008, 14:275-281.
3. Wuthrich M., Gern B., Hung C.Y., Ersland K., Rocco N., Pick-Jacobs J., et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Investig 2011, 121:554-568.
4. Chen K., McAleer J.P., Lin Y., Paterson D.L., Zheng M., Alcorn J.F., et al. Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 2011, 35:997-1009.
5. Hernandez-Santos N., Huppler A.R., Peterson A.C., Khader S.A., McKenna K.C., Gaffen S.L. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol 2013, 6:900-910.
6. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
7. Bordon J., Aliberti S., Fernandez-Botran R., Uriarte S.M., Rane M.J., Duvvuri P., et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 2013, 17:e76-e83.
8. Linden A., Laan M., Anderson G.P. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005, 25:159-172.
9. Curtis J.L., Freeman C.M., Hogg J.C. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 2007, 4:512-521.
10. Dubin P.J., McAllister F., Kolls J.K. Is cystic fibrosis a TH17 disease. Inflamm Res 2007, 56:221-227.
11. Bullens D.M., Truyen E., Coteur L., Dilissen E., Hellings P.W., Dupont L.J., et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir Res 2006, 7:135.
12. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Page N., et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430-438.
13. Barczyk A., Pierzchala W., Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003, 97:726-733.
14. McAllister F., Henry A., Kreindler J.L., Dubin P.J., Ulrich L., Steele C., et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005, 175:404-412.
15. Hizawa N., Kawaguchi M., Huang S.K., Nishimura M. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin Exp Allergy 2006, 36:1109-1114.
16. Mulcahy E.M., Hudson J.B., Beggs S.A., Reid D.W., Roddam L.F., Cooley M.A. High peripheral blood th17 percent associated with poor lung function in cystic fibrosis. PLOS ONE 2015, 10:e0120912.
17. Fahy J.V., Kim K.W., Liu J., Boushey H.A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995, 95:843-852.
18. Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K.F., Barnes P.J. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999, 160:1532-1539.
19. Ramirez-Velazquez C., Castillo E.C., Guido-Bayardo L., Ortiz-Navarrete V. IL-17-producing peripheral blood CD177+ neutrophils increase in allergic asthmatic subjects. Allergy Asthma Clin Immunol 2013, 9:23.
20. Curtis M.M., Way S.S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 2009, 126:177-185.
21. Wan Y.Y., Flavell R.A. How diverse - CD4 effector T cells and their functions. J Mol Cell Biol 2009, 1:20-36.
22. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
23. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
24. Harris T.J., Grosso J.F., Yen H.R., Xin H., Kortylewski M., Albesiano E., et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007, 179:4313-4317.
25. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
26. Das J., Ren G., Zhang L., Roberts A.I., Zhao X., Bothwell A.L., et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 2009, 206:2407-2416.
27. Santarlasci V., Maggi L., Capone M., Frosali F., Querci V., De Palma R., et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol 2009, 39:207-215.
28. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967-971.
29. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007, 8:1390-1397.
30. Yang Y., Weiner J., Liu Y., Smith A.J., Huss D.J., Winger R., et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J Exp Med 2009, 206:1549-1564.
31. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8:942-949.
32. Kryczek I., Wei S., Vatan L., Escara-Wilke J., Szeliga W., Keller E.T., et al. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol 2007, 179:1423-1426.
33. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
34. Durant L., Watford W.T., Ramos H.L., Laurence A., Vahedi G., Wei L., et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010, 32:605-615.
35. Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007, 282:9358-9363.
36. Wei L., Laurence A., Elias K.M., O'Shea J.J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007, 282:34605-34610.
37. Elyaman W., Bradshaw E.M., Uyttenhove C., Dardalhon V., Awasthi A., Imitola J., et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 2009, 106:12885-12890.
38. + T cells prevents development of experimental autoimmune diseases. J Immunol 2008, 180:6070-6076.
39. de Beaucoudrey L., Puel A., Filipe-Santos O., Cobat A., Ghandil P., Chrabieh M., et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008, 205:1543-1550.
40. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
41. Renner E.D., Rylaarsdam S., Anover-Sombke S., Rack A.L., Reichenbach J., Carey J.C., et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 2008, 122:181-187.
42. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998, 9:745-755.
43. Huang H., Paul W.E. Impaired interleukin 4 signaling in T helper type 1 cells. J Exp Med 1998, 187:1305-1313.
44. Huang Z., Xin J., Coleman J., Huang H. IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor. J Immunol 2005, 174:1332-1337.
45. Cooney L.A., Towery K., Endres J., Fox D.A. Sensitivity and resistance to regulation by IL-4 during Th17 maturation. J Immunol 2011, 187:4440-4450.
46. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
47. Osorio F., LeibundGut-Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 2008, 38:3274-3281.
48. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
49. Lochner M., Peduto L., Cherrier M., Sawa S., Langa F., Varona R., et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med 2008, 205:1381-1393.
50. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
51. Tartar D.M., VanMorlan A.M., Wan X., Guloglu F.B., Jain R., Haymaker C.L., et al. FoxP3+ RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes. J Immunol 2010, 184:3377-3385.
52. Voo K.S., Wang Y.H., Santori F.R., Boggiano C., Arima K., Bover L., et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009, 106:4793-4798.
53. Lexberg M.H., Taubner A., Forster A., Albrecht I., Richter A., Kamradt T., et al. Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 2008, 38:2654-2664.
54. Nurieva R., Yang X.O., Chung Y., Dong C. Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J Immunol 2009, 182:2565-2568.
55. Lexberg M.H., Taubner A., Albrecht I., Lepenies I., Richter A., Kamradt T., et al. IFN-gamma and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol 2010, 40:3017-3027.
56. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
57. Nistala K., Adams S., Cambrook H., Ursu S., Olivito B., de Jager W., et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010, 107:14751-14756.
58. Bending D., De la Pena H., Veldhoen M., Phillips J.M., Uyttenhove C., Stockinger B., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Investig 2009, 119:565-572.
59. Yen H.R., Harris T.J., Wada S., Grosso J.F., Getnet D., Goldberg M.V., et al. Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol 2009, 183:7161-7168.
60. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006, 177:4662-4669.
61. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007, 178:3786-3796.
62. Liu J., Qu H., Li Q., Ye L., Ma G., Wan H. The responses of gammadelta T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17. Pathog Dis 2013, 68:44-51.
63. Peng M.Y., Wang Z.H., Yao C.Y., Jiang L.N., Jin Q.L., Wang J., et al. Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis. Cell Mol Immunol 2008, 5:203-208.
64. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007, 204:995-1001.
65. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
66. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
67. Ferretti S., Bonneau O., Dubois G.R., Jones C.E., Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003, 170:2106-2112.
68. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009, 206:35-41.
69. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009, 10:66-74.
70. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009, 10:75-82.
71. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009, 10:83-91.
72. Akimzhanov A.M., Yang X.O., Dong C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J Biol Chem 2007, 282:5969-5972.
73. Rouvier E., Luciani M.F., Mattei M.G., Denizot F., Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993, 150:5445-5456.
74. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995, 3:811-821.
75. Hymowitz S.G., Filvaroff E.H., Yin J.P., Lee J., Cai L., Risser P., et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. Embo J 2001, 20:5332-5341.
76. Liang S.C., Long A.J., Bennett F., Whitters M.J., Karim R., Collins M., et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 2007, 179:7791-7799.
77. Dumoutier L., Louahed J., Renauld J.C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000, 164:1814-1819.
78. Aggarwal S., Xie M.H., Maruoka M., Foster J., Gurney A.L. Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 2001, 21:1047-1053.
79. Dumoutier L., Van Roost E., Colau D., Renauld J.C. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A 2000, 97:10144-10149.
80. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
81. Silva W.A., Covas D.T., Panepucci R.A., Proto-Siqueira R., Siufi J.L., Zanette D.L., et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003, 21:661-669.
82. Moseley T.A., Haudenschild D.R., Rose L., Reddi A.H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 2003, 14:155-174.
83. Haudenschild D., Moseley T., Rose L., Reddi A.H. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J Biol Chem 2002, 277:4309-4316.
84. Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J., et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006, 177:36-39.
85. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008, 14:282-289.
86. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996, 183:2593-2603.
87. Jones C.E., Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002, 26:748-753.
88. Kawaguchi M., Kokubu F., Kuga H., Matsukura S., Hoshino H., Ieki K., et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 2001, 108:804-809.
89. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162:2347-2352.
90. Laan M., Lotvall J., Chung K.F., Linden A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 2001, 133:200-206.
91. Prause O., Laan M., Lotvall J., Linden A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 2003, 462:193-198.
92. Chen Y., Thai P., Zhao Y.H., Ho Y.S., DeSouza M.M., Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003, 278:17036-17043.
93. Kao C.Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 2004, 173:3482-3491.
94. Schwandner R., Yamaguchi K., Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 2000, 191:1233-1240.
95. Liu C., Qian W., Qian Y., Giltiay N.V., Lu Y., Swaidani S., et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2009, 2:ra63.
96. Swaidani S., Bulek K., Kang Z., Liu C., Lu Y., Yin W., et al. The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 2009, 182:1631-1640.
97. Hartupee J., Liu C., Novotny M., Li X., Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 2007, 179:4135-4141.
98. Bulek K., Liu C., Swaidani S., Wang L., Page R.C., Gulen M.F., et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol 2011, 12:844-852.
99. Sun D., Novotny M., Bulek K., Liu C., Li X., Hamilton T. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol 2011, 12:853-860.
100. Herjan T., Yao P., Qian W., Li X., Liu C., Bulek K., et al. HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization. J Immunol 2013, 191:640-649.
101. Nagem R.A., Colau D., Dumoutier L., Renauld J.C., Ogata C., Polikarpov I. Crystal structure of recombinant human interleukin-22. Structure 2002, 10:1051-1062.
102. Kotenko S.V., Izotova L.S., Mirochnitchenko O.V., Esterova E., Dickensheets H., Donnelly R.P., et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001, 276:2725-2732.
103. Xie M.H., Aggarwal S., Ho W.H., Foster J., Zhang Z., Stinson J., et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000, 275:31335-31339.
104. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001, 167:3545-3549.
105. Wang M., Tan Z., Zhang R., Kotenko S.V., Liang P. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 2002, 277:7341-7347.
106. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004, 22:929-979.
107. Dumoutier L., Lejeune D., Colau D., Renauld J.C. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J Immunol 2001, 166:7090-7095.
108. Kotenko S.V., Izotova L.S., Mirochnitchenko O.V., Esterova E., Dickensheets H., Donnelly R.P., et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 2001, 166:7096-7103.
109. Xu W., Presnell S.R., Parrish-Novak J., Kindsvogel W., Jaspers S., Chen Z., et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A 2001, 98:9511-9516.
110. Lejeune D., Dumoutier L., Constantinescu S., Kruijer W., Schuringa J.J., Renauld J.C. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002, 277:33676-33682.
111. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
112. Wolk K., Witte E., Wallace E., Docke W.D., Kunz S., Asadullah K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006, 36:1309-1323.
113. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005, 129:969-984.
114. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A.K., et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Investig 2008, 118:534-544.
115. Witte E., Witte K., Warszawska K., Sabat R., Wolk K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 2010, 21:365-379.
116. Dumoutier L., de Meester C., Tavernier J., Renauld J.C. New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain. J Biol Chem 2009, 284:26377-26384.
117. Ikeuchi H., Kuroiwa T., Hiramatsu N., Kaneko Y., Hiromura K., Ueki K., et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheumatol 2005, 52:1037-1046.
118. Weinberger D.M., Harboe Z.B., Sanders E.A., Ndiritu M., Klugman K.P., Ruckinger S., et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010, 51:692-699.
119. Zhang Z., Clarke T.B., Weiser J.N. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Investig 2009, 119:1899-1909.
120. Wilson R., Cohen J.M., Jose R.J., de Vogel C., Baxendale H., Brown J.S. Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses. Mucosal Immunol 2014.
121. Malley R., Srivastava A., Lipsitch M., Thompson C.M., Watkins C., Tzianabos A., et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 2006, 74:2187-2195.
122. Moffitt K.L., Malley R., Lu Y.J. Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine. PLoS ONE 2012, 7:e43445.
123. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001, 194:519-527.
124. Liu J., Feng Y., Yang K., Li Q., Ye L., Han L., et al. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice. FEMS Immunol Med Microbiol 2011, 61:179-188.
125. Wu W., Huang J., Duan B., Traficante D.C., Hong H., Risech M., et al. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2012, 186:420-427.
126. Kudva A., Scheller E.V., Robinson K.M., Crowe C.R., Choi S.M., Slight S.R., et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 2011, 186:1666-1674.
127. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
128. Garraud K., Cleret A., Mathieu J., Fiole D., Gauthier Y., Quesnel-Hellmann A., et al. Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax. Infect Immun 2012, 80:131-142.
129. Lin J.S., Kummer L.W., Szaba F.M., Smiley S.T. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J Immunol 2011, 186:1675-1684.
130. Mahon B.P., Brady M.T., Mills K.H. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J Infect Dis 2000, 181:2087-2091.
131. Higgins S.C., Jarnicki A.G., Lavelle E.C., Mills K.H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol 2006, 177:7980-7989.
132. Warfel J.M., Merkel T.J. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 2013, 6:787-796.
133. Wu Q., Martin R.J., Rino J.G., Breed R., Torres R.M., Chu H.W. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 2007, 9:78-86.
134. Sieve A.N., Meeks K.D., Bodhankar S., Lee S., Kolls J.K., Simecka J.W., et al. A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur J Immunol 2009, 39:426-438.
135. Rudner X.L., Happel K.I., Young E.A., Shellito J.E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007, 75:3055-3061.
136. Cole G.T., Hung C.Y., Sanderson S.D., Hurtgen B.J., Wuthrich M., Klein B.S., et al. Novel strategies to enhance vaccine immunity against coccidioidomycosis. PLoS Pathog 2013, 9:e1003768.
137. Wuthrich M., LeBert V., Galles K., Hu-Li J., Ben-Sasson S.Z., Paul W.E., et al. Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection. J Infect Dis 2013, 208:1175-1182.
138. Wuthrich M., Ersland K., Sullivan T., Galles K., Klein B.S. Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes. Immunity 2012, 36:680-692.
139. Wang H., LeBert V., Hung C.Y., Galles K., Saijo S., Lin X., et al. C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America. J Immunol 2014, 192:1107-1119.
140. Deepe G.S. Gibbons RS. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J Infect Dis 2009, 200:142-151.
141. Wozniak K.L., Hardison S.E., Kolls J.K., Wormley F.L. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One 2011, 6:e17204.
142. Zhang Y., Wang F., Tompkins K.C., McNamara A., Jain A.V., Moore B.B., et al. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol 2009, 175:2489-2500.
143. Kushwah R., Gagnon S., Sweezey N.B. Intrinsic predisposition of naive cystic fibrosis T cells to differentiate towards a Th17 phenotype. Respir Res 2013, 14:138.
144. Wiehler S., Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2007, 293:L505-L515.
145. + T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010, 125:222-230. e1-4.
146. Alcorn J.F., Crowe C.R., Kolls J.K. TH17 cells in asthma and COPD. Annu Rev Physiol 2010, 72:495-516.
147. Wright A.K., Bangert M., Gritzfeld J.F., Ferreira D.M., Jambo K.C., Wright A.D., et al. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog 2013, 9:e1003274.
148. McDonald D.R. TH17 deficiency in human disease. J Allergy Clin Immunol 2012, 129:1429-1435. quiz 36-7.
149. Christiaansen A.F., Knudson C.J., Weiss K.A., Varga S.M. The CD4 T cell response to respiratory syncytial virus infection. Immunol Res 2014, 59:109-117.
150. de Almeida Nagata D.E., Demoor T., Ptaschinski C., Ting H.A., Jang S., Reed M., et al. IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis. Am J Pathol 2014, 184:1807-1818.
151. Stoppelenburg A.J., de Roock S., Hennus M.P., Bont L., Boes M. Elevated Th17 response in infants undergoing respiratory viral infection. Am J Pathol 2014, 184:1274-1279.
152. Stoppelenburg A.J., Salimi V., Hennus M., Plantinga M., Huis in't Veld R., Walk J., et al. Local IL-17A potentiates early neutrophil recruitment to the respiratory tract during severe RSV infection. PLOS ONE 2013, 8:e78461.
153. Mukherjee S., Lindell D.M., Berlin A.A., Morris S.B., Shanley T.P., Hershenson M.B., et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011, 179:248-258.
154. Schnoeller C., Roux X., Sawant D., Raze D., Olszewska W., Locht C., et al. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Am J Respir Crit Care Med 2014, 189:194-202.
155. McCarthy M.K., Zhu L., Procario M.C., Weinberg J.B. IL-17 contributes to neutrophil recruitment but not to control of viral replication during acute mouse adenovirus type 1 respiratory infection. Virology 2014, 456-457. 259-267.
156. Hamada H., Garcia-Hernandez Mde L., Reome J.B., Misra S.K., Strutt T.M., McKinstry K.K., et al. Tc17, a unique subset of CD8T cells that can protect against lethal influenza challenge. J Immunol 2009, 182:3469-3481.
157. Wang X., Chan C.C., Yang M., Deng J., Poon V.K., Leung V.H., et al. A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection. Cell Mol Immunol 2011, 8:462-468.
158. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006, 203:2271-2279.
159. Lilly L.M., Gessner M.A., Dunaway C.W., Metz A.E., Schwiebert L., Weaver C.T., et al. The beta-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J Immunol 2012, 189:3653-3660.
160. Gessner M.A., Werner J.L., Lilly L.M., Nelson M.P., Metz A.E., Dunaway C.W., et al. Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. Infect Immun 2012, 80:410-417.
161. + T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008, 180:1962-1970.
162. Chan Y.R., Chen K., Duncan S.R., Lathrop K.L., Latoche J.D., Logar A.J., et al. Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes. J Allergy Clin Immunol 2013, 131:1117-1129. 29 e1-5.
163. Pennino D., Bhavsar P.K., Effner R., Avitabile S., Venn P., Quaranta M., et al. IL-22 suppresses IFN-gamma-mediated lung inflammation in asthmatic patients. J Allergy Clin Immunol 2013, 131:562-570.
164. De Luca A., Zelante T., D'Angelo C., Zagarella S., Fallarino F., Spreca A., et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 2010, 3:361-373.
165. Guo H., Topham D.J. Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection. J Virol 2010, 84:7750-7759.
166. Monticelli L.A., Sonnenberg G.F., Abt M.C., Alenghat T., Ziegler C.G., Doering T.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12:1045-1054.
167. Paget C., Ivanov S., Fontaine J., Renneson J., Blanc F., Pichavant M., et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem 2012, 287:8816-8829.
168. Kumar P., Thakar M.S., Ouyang W., Malarkannan S. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol 2013, 6:69-82.
169. Pociask D.A., Scheller E.V., Mandalapu S., McHugh K.J., Enelow R.I., Fattman C.L., et al. IL-22 is essential for lung epithelial repair following influenza infection. Am J Pathol 2013, 182:1286-1296.
170. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921.
171. Finco O., Frigimelica E., Buricchi F., Petracca R., Galli G., Faenzi E., et al. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc Natl Acad Sci U S A 2011, 108:9969-9974.
172. Jing L., McCaughey S.M., Davies D.H., Chong T.M., Felgner P.L., De Rosa S.C., et al. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J Immunol Methods 2009, 347:36-45.
173. + T-cells expression cloning. Vaccine 2009, 27:223-233.
174. Jing L., Chong T.M., Byrd B., McClurkan C.L., Huang J., Story B.T., et al. Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus. J Immunol 2007, 178:6374-6386.
175. Jing L., Haas J., Chong T.M., Bruckner J.J., Dann G.C., Dong L., et al. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J Clin Investig 2012, 122:654-673.
176. Turner M.J., Abdul-Alim C.S., Willis R.A., Fisher T.L., Lord E.M., Frelinger J.G. T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes. J Immunol Methods 2001, 256:107-119.
177. Picard M.D., Cohane K.P., Gierahn T.M., Higgins D.E., Flechtner J.B. High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge. Vaccine 2012, 30:4387-4393.
178. Skoberne M., Cardin R., Lee A., Kazimirova A., Zielinski V., Garvie D., et al. An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs. J Virol 2013, 87:3930-3942.
179. Moffitt K.L., Gierahn T.M., Lu Y.J., Gouveia P., Alderson M., Flechtner J.B., et al. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 2011, 9:158-165.
180. Li Y., Gierahn T., Thompson C.M., Trzcinski K., Ford C.B., Croucher N., et al. Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. PLoS Pathog 2012, 8:e1002989.
181. Barry M.A., Howell D.P., Andersson H.A., Chen J.L., Singh R.A. Expression library immunization to discover and improve vaccine antigens. Immunol Rev 2004, 199:68-83.
182. Talaat A.M., Stemke-Hale K. Expression library immunization: a road map for discovery of vaccines against infectious diseases. Infect Immun 2005, 73:7089-7098.
183. Pulido J., Kottke T., Thompson J., Galivo F., Wongthida P., Diaz R.M., et al. Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. Nat Biotechnol 2012, 30:337-343.
184. Lee Y., Awasthi A., Yosef N., Quintana F.J., Xiao S., Peters A., et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 2012, 13:991-999.
185. Peters A., Lee Y., Kuchroo V.K. The many faces of Th17 cells. Curr Opin Immunol 2011, 23:702-706.
186. Wu C., Yosef N., Thalhamer T., Zhu C., Xiao S., Kishi Y., et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.